SCHEMBL7089627

SCHEMBL7089627

O=C1CCC2(CC1Cc1ccccc1Br)OCCO2

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP27A1 Q02318 1/20 0.37
CYP24A1 Q07973 1/20 0.37
SLC6A4 P31645 2/20 0.33
CYP2A13 Q16696 1/20 0.33
NR3C1 P04150 1/20 0.32
ATM Q13315 1/20 0.32
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30
MMP12 P39900 1/20 0.30
HCRTR2 O43614 1/20 0.30
DRD2 P14416 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7088298 0.84 CYP27A1 (0.33) CYP27A1CYP24A1SLC6A4CYP2A13ATM
SCHEMBL17592658 0.81 DDB1 (0.43)
SCHEMBL8538917 0.78 POLB (0.36) PTGS1PTGS2
SCHEMBL1709368 0.73 PPARG (0.35)
SCHEMBL30825588 0.71 PTGS1 (0.52) CYP27A1CYP24A1ATMPTGS1PTGS2
SCHEMBL9296486 0.71 PTGS1 (0.52) CYP27A1CYP24A1ATMPTGS1PTGS2
SCHEMBL29169537 0.71 PTGS1 (0.52) CYP27A1CYP24A1ATMPTGS1PTGS2
SCHEMBL21754408 0.71 ALDH1A1 (0.47)
SCHEMBL17592593 0.70 KMT2A (0.31)
SCHEMBL30727008 0.70 C5AR1 (0.36) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010694-B1 Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers SERVIER LAB (FR) 2003-08-06 EP disclosed
US-6172097-B1 Spiro imidazoline compounds ADIR ET COMPAGNIE (FR) 2001-01-09 US disclosed
EP-1010694-A2 Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers ADIR ET COMPAGNIE (FR) 2000-06-21 EP disclosed